Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TIE2 receptor, also known as Angiopoietin-1 receptor or TEK tyrosine kinase, is a receptor tyrosine kinase primarily expressed in endothelial cells. It is essential for blood vessel maturation, remodeling, and stability during embryonic development and postnatal angiogenesis. Aberrant TIE2 signaling is implicated in various vascular diseases including venous malformations and cancer-related angiogenesis. It interacts with Angiopoietin-1 (agonist) and Angiopoietin-2 (context-dependent agonist/antagonist).
Agonist-mediated receptor activation; Antagonist-mediated receptor inhibition; Inhibition of receptor tyrosine kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIE2 Receptor (TIE2).